MetLife, Inc. (NYSE:MET) Shares Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lifted its stake in shares of MetLife, Inc. (NYSE:METFree Report) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,741 shares of the financial services provider’s stock after purchasing an additional 1,249 shares during the period. Oppenheimer & Co. Inc.’s holdings in MetLife were worth $2,435,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC boosted its stake in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. lifted its stake in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after buying an additional 186 shares in the last quarter. Peterson Financial Group Inc. acquired a new position in MetLife during the third quarter worth about $30,000. Retirement Wealth Solutions LLC purchased a new stake in MetLife during the 4th quarter valued at about $32,000. Finally, Sierra Ocean LLC acquired a new stake in MetLife in the 4th quarter valued at about $32,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Performance

Shares of MET stock opened at $86.16 on Monday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market cap of $58.69 billion, a P/E ratio of 14.43, a P/E/G ratio of 0.65 and a beta of 1.07. The firm’s 50 day moving average price is $83.65 and its 200-day moving average price is $81.99. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is currently 36.52%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on MET. BMO Capital Markets assumed coverage on MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 target price on the stock. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. raised their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company boosted their price target on shares of MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. Finally, Keefe, Bruyette & Woods cut their price objective on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research report on Wednesday, February 12th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $94.58.

Check Out Our Latest Analysis on MET

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.